Eric P. Winer, MD, Yale Cancer Center (YCC) Director and physician-in-chief of Smilow Cancer Hospital, has announced further investment in YCC's Hematology/Oncology Fellowship Program with a $1.5 million commitment to the program. This will ensure an even steeper trajectory for the program with new programmatic development and individual support for fellows to pursue educational opportunities and research projects, and launch their careers at Yale Cancer Center.
The Hematology/Oncology Fellowship Program has been a keystone of YCC's education and training mission since its inception in 1964—training leaders in research, clinical care, industry, and every sector of hematology and oncology. Jill Lacy, MD, professor of medicine, led the program for over two decades with vision, creativity, and commitment, providing an outstanding educational and research experience for the fellows.
In 2020, Alfred I. Lee, MD, PhD, was appointed director of the program. Dr. Lee’s passion and dedication to the growth, mentorship, and prospects for our trainees has propelled our program even further to provide new opportunities for basic, translational, population, and clinical research.
“I am honored to have the Cancer Center’s generous support to continue to build on the existing strengths of our program, and expand the opportunities we provide to our fellows,” said Dr. Lee who is also associate professor of medicine (hematology). “With this renewed level of commitment, the possibilities are endless.”
We are committed to providing the resources needed to mentor our next generation of hematologists and oncologists, and will focus on addressing the individual needs of each and every one of fellows.
Dr. Eric Winer
Dr. Lee will work closely with Roy S. Herbst, MD, PhD, Deputy Director for Clinical Affairs and Chief of Medical Oncology, Stephanie Halene, MD, PhD, Chief of Hematology, and the associate directors of the Fellowship Program, to plan and implement new resources over the coming years, including expanding the core faculty mentors to include basic and translational scientists at Yale Cancer Center, retaining fellows post-fellowship, and providing fellows funding to support additional academic goals at Yale.
“Alfred’s innovative ideas for our fellowship program and commitment to providing our fellows with an unparalleled education during their tenure at Yale Cancer Center and Smilow Cancer Hospital will continue to propel our training program forward,” said Dr. Winer. “We are committed to providing the resources needed to mentor our next generation of hematologists and oncologists, and will focus on addressing the individual needs of each and every one of fellows.”